Royalty Pharma plc RPRX

Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation

GlobeNewswire Inc. · 92d ago

Royalty Pharma Declares Second Quarter 2026 Dividend

Benzinga · 96d ago

Zymeworks Appoints Kristin Stafford as Chief Financial Officer

GlobeNewswire Inc. · 112d ago

Vera Therapeutics Appoints Christopher Hite to Board of Directors

GlobeNewswire Inc. · 139d ago

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

GlobeNewswire Inc. · 142d ago

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation

GlobeNewswire Inc. · 191d ago

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

GlobeNewswire Inc. · 191d ago

Royalty Pharma Announces Dividend Increase

Benzinga · 194d ago

Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight

Benzinga · 194d ago

What's Going On With Royalty Pharma Stock Wednesday?

Benzinga · 203d ago

Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones

Benzinga · 204d ago

Cytokinetics Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire Inc. · 258d ago

Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes

GlobeNewswire Inc. · 322d ago

Royalty Pharma to Acquire Royalty Interest in Amgen's Imdelltra for up to $950 Million

Benzinga · 331d ago

Royalty Pharma Completes the Acquisition of Its External Manager

Benzinga · 431d ago

Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma

Benzinga · 525d ago

Royalty Pharma Announces Transformative Step in Company's Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program

Benzinga · 558d ago

3 High-Yield Dividend Stocks to Buy in 2025 and Hold for a Decade or Longer

The Motley Fool · 586d ago

2 Exceptional Dividend Stocks Near 52-Week Lows You Could Regret Not Buying on the Dips

The Motley Fool · 595d ago

3 Dividend Growth Stocks to Buy Now for a Lifetime of Passive Income

The Motley Fool · 640d ago

2 No-Brainer Dividend Stocks to Buy With $100 in October

The Motley Fool · 659d ago

Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib

GlobeNewswire Inc. · 714d ago

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Zacks Investment Research · 764d ago